Lakewood-Amedex Biotherapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 0.2 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 473.94K

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biother...